Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions

Bridget F Grant, S Patricia Chou, Risë B Goldstein, Boji Huang, Frederick S Stinson, Tulshi D Saha, Sharon M Smith, Deborah A Dawson, Attila J Pulay, Roger P Pickering, W June Ruan, Bridget F Grant, S Patricia Chou, Risë B Goldstein, Boji Huang, Frederick S Stinson, Tulshi D Saha, Sharon M Smith, Deborah A Dawson, Attila J Pulay, Roger P Pickering, W June Ruan

Abstract

Objectives: To present nationally representative findings on prevalence, sociodemographic correlates, disability, and comorbidity of borderline personality disorder (BPD) among men and women.

Method: Face-to-face interviews were conducted with 34,653 adults participating in the 2004-2005 Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Personality disorder diagnoses were made using the Wave 2 Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM-IV Version.

Results: Prevalence of lifetime BPD was 5.9% (99% CI = 5.4 to 6.4). There were no differences in the rates of BPD among men (5.6%, 99% CI = 5.0 to 6.2) and women (6.2%, 99% CI = 5.6 to 6.9). BPD was more prevalent among Native American men, younger and separated/divorced/widowed adults, and those with lower incomes and education and was less prevalent among Hispanic men and women and Asian women. BPD was associated with substantial mental and physical disability, especially among women. High co-occurrence rates of mood and anxiety disorders with BPD were similar. With additional comorbidity controlled for, associations with bipolar disorder and schizotypal and narcissistic personality disorders remained strong and significant (odds ratios > or = 4.3). Associations of BPD with other specific disorders were no longer significant or were considerably weakened.

Conclusions: BPD is much more prevalent in the general population than previously recognized, is equally prevalent among men and women, and is associated with considerable mental and physical disability, especially among women. Unique and common factors may differentially contribute to disorder-specific comorbidity with BPD, and some of these associations appear to be sex-specific. There is a need for future epidemiologic, clinical, and genetically informed studies to identify unique and common factors that underlie disorder-specific comorbidity with BPD. Important sex differences observed in rates of BPD and associations with BPD can inform more focused, hypothesis-driven investigations of these factors.

References

    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
    1. McGlashan TH, Grilo CM, Skodol AE, Gunderson JG, Shea MT, Morey LC, Zanarini MC, Stout RL. The Collaborative Longitudinal Study: baseline Axis I/II and II/II diagnostic co-occurrence. Acta Psychiatr Scand. 2000;102:256–264.
    1. Paris J. Borderline Personality Disorder. Washington, DC: American Psychiatric Press; 1993.
    1. Sansone RA. Chronic suicidality and borderline personality. J Personal Disord. 2004;18:215–225.
    1. Skodol AE, Gunderson JG, Pfohl B, Widiger TA, Livesley WJ, Siever LJ. The borderline diagnosis. I: psychopathology, comorbidity, and personality structure. Biol Psychiatry. 2002;51:936–950.
    1. Oldham JM, Skodol AE, Kellman HD, Hyler SE, Doidge N, Rosnick L, Gallaher PE. Comorbidity of Axis I and II disorders. Am J Psychiatry. 1995;152:571–578.
    1. Skodol AE, Stout RL, McGlashan TH, Grilo CM, Gunderson JG, Shea MT, Morey LC, Zanarini MC, Dyck IR, Oldham JM. Co-occurrence of mood and personality disorders: a report from the Collaborative Longitudinal Personality Disorders Study (CLPS) Depress Anxiety. 1999;10:175–182.
    1. Trull TJ, Sher KJ, Minks-Brown C, Durbin J, Burr R. Borderline personality disorder and substance use disorders: a review and integration. Clin Psychol Rev. 2000;20:235–253.
    1. Zanarini MC, Frankenburg FR, Dubo ED, Sickel MA, Trikha A, Levin A, Reynolds V. Axis I comorbidity of borderline personality disorder. Am J Psychiatry. 1998;152:1733–1739.
    1. Zanarini MC, Gunderson JG, Frankenburg FR. Axis I phenomenology of borderline personality disorder. Compr Psychiatry. 1989;30:149–156.
    1. Zimmerman M, Mattia JI. Axis I comorbidity and borderline personality disorder. Compr Psychiatry. 1999;40:245–252.
    1. Zimmerman M, Rothschild L, Chelminski I. The prevalence of personality disorders in psychiatric outpatients. Am J Psychiatry. 2005;162:1911–1918.
    1. Black DW, Noyes R, Jr, Pfohl B, Goldstein RB, Blum N. Personality disorder in obsessive-compulsive volunteers, well comparison subjects, and their first-degree relatives. Am J Psychiatry. 1993;150:1226–1232.
    1. Bodlund O, Ekselius L, Lindstrom E. Personality traits and disorders among psychiatric outpatients and normal subjects on the basis of the SCID screen questionnaire. Nord Psykiatr Tidsskr. 1993;47:425–433.
    1. Coid J, Yang M, Tyrer P, Roberts A, Ullrich S. Prevalence and correlates of personality disorder in Great Britain. Br J Psychiatry. 2006;188:423–431.
    1. Drake RE, Adler DA, Vaillant GE. Antecedents of personality disorders in a community sample of men. J Personal Disord. 1988;2:60–68.
    1. Ekselius L, Tillfors M, Furmark T, Fredrikson M. Personality disorders in the general population: DSM-IV and ICD-10 defined prevalence as related to sociodemographic profile. Pers Indiv Diff. 2001;30:311–320.
    1. Klein DN, Riso LP, Donaldson SK, Schwartz JE, Anderson RL, Ouimette PC, Lizardi H, Aronson TA. Family study of early-onset dysthymia: mood and personality disorders in relatives of outpatients of dysthymia and episodic major depression and normal controls. Arch Gen Psychiatry. 1995;52:487–496.
    1. Lenzenweger MF, Lane MC, Loranger AW, Kessler RC. DSM-IV personality disorders in the National Comorbidity Survey Replication. Biol Psychiatry. 2007 In press.
    1. Lenzenweger MF, Loranger AW, Korfine L, Neff C. Detecting personality disorders in a nonclinical population: application of a 2-stage procedure for case identification. Arch Gen Psychiatry. 1997;54:345–351.
    1. Maier W, Lichtermann D, Klingler T, Heun R, Hallmayer J. Prevalences of personality disorders (DSM-III-R) in the community. J Personal Disord. 1992;6:187–196.
    1. Moldin SO, Rice JP, Erlenmeyer-Kimling L, Squires-Wheeler E. Latent structure of DSM-III-RAxis II psychopathology in a normal sample. J Abnorm Psychol. 1994;103:259–266.
    1. Reich J, Yates W, Nduaguba M. Prevalences of DSM-IIIpersonality disorders in the community. Soc Psychiatry Psychiatr Epidemiol. 1989;24:12–16.
    1. Samuels JF, Nestadt G, Romanoski AJ, Folstein MF, McHugh PR. DSM-III personality disorders in the community. Am J Psychiatry. 1994;151:1055–1062.
    1. Sar V, Akyuz G, Dogan O. Prevalence of dissociative disorders among women in the general population. Psychiatry Res. 2007;149:169–176.
    1. Swartz M, Blazer D, George L, Winfield I. Estimating the prevalence of borderline personality disorder in the community. J Personal Disord. 1990;4:257–272.
    1. Zimmerman M, Coryell W. DSM-IIIpersonality disorder diagnoses in a nonpatient sample: demographic correlates and comorbidity. Arch Gen Psychiatry. 1989;46:682–689.
    1. Torgersen S, Kringlen E, Cramer V. The prevalence of personality disorders in a community sample. Arch Gen Psychiatry. 2001;58:590–596.
    1. Jackson HJ, Burgess PM. Personality disorders in a community: a report rom the Australian National Survey of Mental Health and Well-Being. Soc Psychiatry Psychiatr Epidemiol. 2000;35:531–588.
    1. Grant BF, Kaplan KK, Stinson FS. Source and Accuracy Statement for the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2005. [Accessed November 1, 2007]. .
    1. Grant BF, Moore TC, Shepard J, Kaplan K. Source and Accuracy Statement: Wave 1 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) National Institute on Alcohol Abuse and Alcoholism Web Site. [Accessed July 2, 2007]. .
    1. Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, Pickering RP, Kaplan K. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61:807–816.
    1. Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007;64:566–576.
    1. Hasin DS, Stinson FS, Ogburn E, Grant BF. Prevalence, correlates, disability and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007;64:830–842.
    1. Grant BF, Dawson DA, Hasin DS. The Alcohol Use Disorders and Associated Disabilities Interview Schedule DSM-IV Version. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2001. [Accessed November 1, 2007]. .
    1. Grant BF, Dawson DA, Hasin DS. The Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions Alcohol Use Disorder and Associated Disabilities Interview Schedule DSM-IV Version. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2004. [Accessed November 1, 2007]. .
    1. Compton WM, Conway KP, Stinson FS, Colliver JD, Grant BF. Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2005;66:677–685.
    1. Grant BF, Hasin DS, Stinson FS, Dawson DA, Chou SP, Ruan WJ, Huang B. Co-occurrence of 12-month mood and anxiety disorders and personality disorders in the U.S.: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Psychiatr Res. 2005;39:1–9.
    1. Grant BF, Hasin DS, Stinson FS, Dawson DA, Chou SP, Ruan WJ, Pickering RP. Prevalence, correlates, and disability of personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2004;65:948–958.
    1. First MB, Gibbon M, Spitzer RL, Williams JBW, Benjamin LS. User’s Guide for the Structured Clinical Interview for DSM-IV Personality Disorders. Washington, DC: American Psychiatric Press; 1997.
    1. Loranger AW. International Personality Disorder Examination: DSM-IV and ICD-10 Interviews. Odessa, FL: Psychological Assessment Resources; 1999.
    1. Zanarini MC, Frankenbureg FR, Sickel AE, Young L. The Diagnostic Interview for DSM-IV Personality Disorders. Belmont, MA: McLean Hospital, Laboratory for the Study of Adult Development; 1996.
    1. Grant BF, Dawson DA, Stinson FS, Chou PS, Kay W, Pickering R. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend. 2003;71:7–16.
    1. Ruan WJ, Goldstein RB, Chou SP, Smith SM, Saha TD, Pickering RP, Dawson DA, Huang B, Stinson FS, Grant BF. The Alcohol Use Disorder and Associated Disabilities Interview Schedule IV (AUDADIS-IV): reliability of new psychiatric diagnostic modules and risk factors in a general population sample. Drug Alcohol Depend. 2007 In press.
    1. Zimmerman M. Diagnosing personality disorders: a review of issues and research methods. Arch Gen Psychiatry. 1994;51:225–245.
    1. Canino GJ, Bravo M, Ramírez R, Febo V, Fernandez R, Hasin DS. The Spanish Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS: reliability and concordance with clinical diagnoses in a Hispanic population. J Stud Alcohol. 1999;60:790–799.
    1. Chatterji S, Saunders JB, Vrasti R, Grant BF, Hasin D, Mager D. Reliability of the alcohol and drug modules of the Alcohol Use Disorder and Associated Disabilities Interview Schedule Alcohol/Drug-Revised (AUDADIS-ADR): an international comparison. Drug Alcohol Depend. 1997;47:171–185.
    1. Grant BF, Harford TC, Dawson DA, Chou PS, Pickering RP. The Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample. Drug Alcohol Depend. 1995;39:37–44.
    1. Hasin D, Carpenter KM, McCloud S, Smith M, Grant BF. The Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample. Drug Alcohol Depend. 1997;44:133–141.
    1. Hasin D, Paykin A. Alcohol dependence and abuse diagnoses: concurrent validity in a nationally representative sample. Alcohol Clin Exp Res. 1999;23:144–150.
    1. Hasin DS, Grant B, Endicott J. The natural history of alcohol abuse: implications for definitions of alcohol use disorders. Am J Psychiatry. 1990;147:1537–1541.
    1. Hasin DS, Muthén, Wisnicki KS, Grant BF. Validity of the bi-axial dependence concept: a test in the U.S. general population. Addiction. 1994;89:573–579.
    1. Hasin DS, Van Rossem R, Endicott J. Differentiating DSM-IV alcohol dependence and abuse by course: community heavy drinkers. J Subst Abuse. 1997;9:127–135.
    1. Hasin DS, Schuckit MA, Martin CS, Grant BF, Bucholz KK, Helzer JE. The validity of DSM-IV alcohol dependence: what do we know and what do we need to know? Alcohol Clin Exp Res. 2003;27:244–252.
    1. Cottler LB, Grant BF, Blaine J, Mavreas V, Pull C, Hasin D, Compton WM, Rubio-Stipec M, Mager D. Concordance of DSM-IV alcohol and drug use disorder criteria and diagnoses as measured by AUDADIS-ADR, CIDI and SCAN. Drug Alcohol Depend. 1997;47:195–205.
    1. Hasin DS, Grant BF, Cottler L, Blaine J, Towle L, Üstün B, Sartorius N. Nosological comparisons of alcohol and drug diagnoses: a multisite, multi-instrument international study. Drug Alcohol Depend. 1997;47:217–226.
    1. Nelson CB, Rehm J, Üstün B, Grant BF, Chatterji S. Factor structure of DSM-IV substance use disorder criteria endorsed by alcohol, cannabis, cocaine and opiate users: results from the World Health Organization Reliability and Validity Study. Addiction. 1999;94:843–855.
    1. Pull CB, Saunders JB, Mavreas V, Cottler LB, Grant BF, Hasin DS, Blaine J, Mager D, Üstün BT. Concordance between ICD-10 alcohol and drug use disorder criteria and diagnoses as measured by the AUDADIS-ADR, CIDI and SCAN: results of a cross-national study. Drug Alcohol Depend. 1997;47:207–216.
    1. Üstün B, Compton W, Mager D, Babor T, Baiyewu O, Chatterji S, Cottler L, Gogus A, Mavreas V, Peters L, Pull C, Saunders J, Smeets R, Stipec MR, Vrasti R, Hasin D, Room R, van den Brink W, Regier D, Blaine J, Grant BF, Sartorius N. WHO Study on the reliability and validity of the alcohol and drug use disorder instruments: overview of methods and results. Drug Alcohol Depend. 1997;47:161–170.
    1. Vrasti R, Grant BF, Chatterji S, Üstün BT, Mager D, Olteanu I, Badoi M. Reliability of the Romanian version of the alcohol module of the WHO Alcohol Use Disorder and Associated Disabilities Interview Schedule Alcohol/Drug Revised. Eur Addict Res. 1998;4:144–149.
    1. Hasin DS, Goodwin RD, Stinson FS, Grant BF. The epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2005;62:1097–1106.
    1. Grant BF, Hasin DS, Blanco C, Stinson FS, Chou SP, Goldstein RB, Dawson DA, Smith S, Saha TD, Huang B. The epidemiology of social anxiety disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2005;66:1351–1361.
    1. Grant BF, Hasin DS, Stinson FS, Dawson DA, Goldstein RB, Smith SM, Huang B, Saha TD. The epidemiology of DSM-IV panic disorder and agoraphobia in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2006;67:363–374.
    1. Grant BF, Hasin DS, Stinson FS, Dawson DA, Ruan WJ, Goldstein RB, Smith SM, Saha TD, Huang B. Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med. 2005;35:1747–1759.
    1. Grant BF, Stinson FS, Hasin DS, Dawson DA, Chou SP, Ruan WJ, Huang B. Prevalence, correlates, and comorbidity of bipolar I disorder and Axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2005;66:1205–1215.
    1. Stinson FS, Dawson DA, Chou SP, Smith S, Goldstein RB, Ruan WJ, Grant BF. The epidemiology of specific phobia in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med. 2007;37:1–13.
    1. Gandek B, Ware JE, Aaronson NK, Alonso J, Apolone G, Bjorner J, Bazier J, Bullinger M, Fukuhara S, Kaasa S, Lepilege A, Sullivan M. Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51:1149–1158.
    1. Research Triangle Institute. Software for Survey Data Analysis (SUDAAN), Version 9.2. Research Triangle Park, NC: Research Triangle Institute; 2006.
    1. Widiger TA. Invited essay: sex biases in the diagnosis of personality disorders. J Personal Disord. 1998;12:95–118.
    1. Morey LC, Alexander GM, Boggs C. Gender. In: Oldham JM, Skodol AE, Bender DS, editors. Textbook of Personality Disorders. Washington, DC: American Psychiatric Publishing, Inc.; 2005. pp. 541–549.
    1. Zlotnick C, Rothschild L, Zimmerman M. The role of gender in the clinical presentation of patients with borderline personality disorder. J Personal Disord. 2002;16:277–282.
    1. Skodal AE, Bender DS. Why are women diagnosed borderline more than men? Psychiatr Quart. 2003;74:349–360.
    1. Grilo CM, Anez LM, McGlashan TH. DSM-IV axis II comorbidity with borderline personality disorder in monolingual Hispanic psychiatric outpatients. J Nerv Ment Dis. 2002;190:324–330.
    1. Grilo CM, Sanislow CA, McGlashan TH. Co-occurrence of DSM-IV personality disorders with borderline personality disorder. J Nerv Ment Dis. 2002;190:552–554.
    1. Johnson DM, Shea MT, Yen S, Battle CL, Zlotnick C, Sanislow CA, Grilo CM, Skodol AE, Bender DS, McGlashan TH, Gunderson JG, Zanarini MC. Gender differences in borderline personality disorder: findings from the Collaborative Longitudinal Personality Disorders Study. Compr Psychiatry. 2003;44:284–292.
    1. Zanarini MC, Frankenburg FR, Dubo ED, Sickel AE, Trikha A, Levin A, Reynolds VR. Axis II comorbidity of borderline personality disorder. Compr Psychiatry. 1998;39:296–302.
    1. Chivara DA, Grilo CM, Shea MT, Yen S, Gunderson JG, Morey LC, Skodol AE, Stout RL, Zanarini MC, McGlashan TH. Ethnicity and four personality disorders. Compr Psychiatry. 2003;44:483–491.
    1. Zanarini MC, Frankenburg FR, Hennen J, Reich B, Silk KR. The McLean Study of Adult Development (MSAD): overview and implications of the first six years of prospective follow-up. J Personal Disord. 2005;19:505–523.
    1. Zanarini MC, Frankenburg FR, Hennen J, Silk KR. The longitudinal course of borderline psychopathology: 6-year prospective follow-up of the phenomenology of borderline personality disorder. Am J Psychiatry. 2003;160:274–283.
    1. Zanarini MC, Frankenburg FR, Hennen J, Reich B, Silk KR. Prediction of the 10-year course of borderline personality disorder. Am J Psychaitry. 2006;163:827–832.
    1. Coid JW. An affective syndrome in psychopaths with borderline personality disorder. Br J Psychiatry. 1993;162:641–650.
    1. Dahl AA. Some aspects of the DSM-III personality disorders illustrated by a consecutive sample of hospitalized patients. Acta Psychiatr Scand Suppl. 1986;328:61–67.
    1. Frances A, Clarkin JF, Gilmore M, Hurt SW, Brown R. Reliability of criteria for borderline personality disorder: a comparison of DSM-III and the Diagnostic Interview for Borderline Patients. Am J Psychiatry. 1984;141:1080–1084.
    1. Hudziak JJ, Boffeli TJ, Kriesman JJ, Battaglia MM, Stanger C, Guze SB. Clinical study of the relation of borderline personality disorder to Briquet’s syndrome (hysteria), somatization disorder, antisocial personality disorder, and substance abuse disorders. Am J Psychiatry. 1996;153:1598–1606.
    1. Koenigsberg HW, Kaplan RD, Gilmore MM, Cooper AM. The relationship between syndrome and personality disorder in DSM-III: experience with 2,462 patients. Am J Psychiatry. 1985;142:207–212.
    1. Links PS, Steiner M, Offord DR, Eppel A. Characteristics of borderline personality disorder: a Canadian study. Can J Psychiatry. 1988;33:336–340.
    1. Beauclair L, Fontaine R, Annable L, Holobow N, Chouinard G. Clonazepam in the treatment of panic disorder: a double-blind, placebo-controlled trial investigating the correlation between clonazepam concentration in plasma and clinical response. J Clin Psychopharmacol. 1994;14:111–114.
    1. Griest J, Chouinard G, DuBoff E, Halaris A, Kim SW, Koran L, Liebowitz M, Lydiard RB, Rasmussen S, White K, Sikes C. Double-blind parallel comparison of three doses of sertraline and placebo in outpatients with obsessive-compulsive disorder. Arch Gen Psychiatry. 1995;52:289–295.
    1. Jefferson JW. Antidepressants in panic disorder. J Clin Psychiatry. 1997;58(suppl 2):20–24.
    1. Mancini C, Van Ameringen M. Paroxetine in social phobia. J Clin Psychiatry. 1996;57:519–522.
    1. Oehrberg S, Christensen PE, Behnke K, Borup AL, Severin B, Soegaard J, Calberg H, Judge R, Ohstrom JK, Manniche PM. Paroxetine in the treatment of panic disorder: a randomized double-blind, placebo-controlled study. Br J Psychaitry. 1995;167:373–379.
    1. Rosenbaum JF, Pollack RA. The psychopharmacology of social phobia and comorbid disorders. Bull Menninger Clin. 1994;52(suppl A):67–83.
    1. Tollefson GD, Rampey AH, Potvin JH, Jenike MA, Rush AJ, Dominguez RA, Koran LM, Shear MK, Goodman W, Genduso LA. A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry. 1994;51:559–567.
    1. Zohar J, Judge R OCD Paroxetine Study Investigators. Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. Br J Psychiatry. 1996;169:468–474.
    1. Christensen H, Hadzi-Pavlovic D, Andrews G, Mattick R. Behavior therapy and tricyclic medication in the treatment of obsessive-compulsive disorder. J Consult Clin Psychol. 1987;55:701–711.
    1. Gould RA, Otto MW, Pollack MH. A meta-analysis of treatment outcome for panic disorder. Clin Psychol Rev. 1995;15:819–844.
    1. Skodol AE, Gunderson JG, McGlashan TH, Dyke IR, Stout RL, Bender DS. Functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder. Am J Psychiatry. 2002;159:276–283.
    1. Smith TL, Benjamin LS. The functional impairment associated with personality disorders. Curr Opin Psychiatry. 2002;15:135–141.
    1. Cramer V, Torgersen S, Kringlen E. Personality disorders and quality of life: a population study. Compr Psychiatry. 2006;47:178–184.
    1. Jackson HJ, Burgess PM. Personality disorders in the community: results from the Australian National Survey on Mental Health and Well-Being Part III. Relationships between specific type of personality disorder, Axis I mental disorders and physical conditions with disability and health consultations. Soc Psychiatry Psychiatr Epidemiol. 2004;39:765–776.
    1. Gunderson JG, Daverson MT, Gilo CM, McGlashon TH, Zanarini MC, Shea MT, Skodol AE, Yen S, Sanislow CA, Bender DS, Dyke IR, Morey LC, Stout RL. Predictors of 2-year outcome for patients with borderline personality disorder. Am J Psychiatry. 2006;163:822–826.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться